Organogenesis Holdings Inc

Organogenesis Holdings Inc Stock

16.45P/E
€93.37MMarket capitalisation
-US$1.20Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Organogenesis Holdings Inc is registered in the following country: United States of America (Exchange: USNASD).

Key metrics

Key metrics and master data for the Organogenesis Holdings Inc stock.

Market capitalisation
€93.37M
P/E
16.45
P/B
0.84
P/S
0.30
P/CF
9.89
Issued shares 130M Units

Return

Here you can see the performance of the Organogenesis Holdings Inc stock.

PeriodPerfor­mance
1 Week-20.34 %
1 Month-20.79 %
3 Months-56.21 %
6 Months-66.11 %
1 Year-83.98 %
YTD-83.83 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the Organogenesis Holdings Inc share.

DateRatio
No data available.

Which ETF contains the Organogenesis Holdings Inc stock?

The Organogenesis Holdings Inc stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Organogenesis Holdings Inc has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Organogenesis Holdings Inc stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.